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Abstract
The innate immune system is one of the first lines of defense against pathogens. RIG-I like
receptors (RLRs) are a class of cytosolic receptors that recognize molecular patterns of invading
pathogens and signal for downstream interferon induction. The RLR family consists of three
proteins, RIG-I, MDA5, and LGP2. MDA5 and LGP2 work together to recognize and bind long
viral dsRNA. LGP2 is thought to regulate MDA5 activation, but little is understood about this
process. Characterization of the mechanism of action of these receptors requires careful
biophysical and biochemical analyses. I have developed expression and purification of methods
LGP2 and MDA5 in E. coil, by determining an appropriate cell line for expression and
optimizing purification conditions. These methods will be utilized for production of LGP2 and
MDA5 in large quantities necessary for biophysical and biochemical analyses. This work has
provided the initial steps necessary for characterizing activation of LGP2 and MDA5 that will be
beneficial for understanding innate immune processes.
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Introduction
RLRs
The innate immune system is one of the first lines of defense against pathogens.
RIG-I like receptors (RLRs) are a class of cytosolic receptors that recognize molecular patterns
of invading pathogens and signal for downstream interferon induction (1). Although these
receptors are very important in innate immunity, many rigorous biophysical analyses have been
impeded due to the difficulty of recombinant expression and purification of these proteins.
Optimization of purification of these proteins is necessary for better understanding their function.
The mammalian innate immune system serves to recognize and eliminate
pathogens by recognizing conserved pathogen associated molecular patterns (PAMPs) (1). More
specifically, higher eukaryotes use the innate immune system to detect viruses and other various
microbes. These patterns include bacterial cell wall components or nucleic acids (1). One class of
cytosolic receptors termed RIG-I like receptors (RLRs) act as a first line of defense to recognize
molecular patterns of invading pathogens and signal for downstream interferon induction.
Interferon induction can occur by signaling pathways that lead to the activation of Interferon
regulatory factor 3 (1RF3), interferon regulatory factor 7 (fflF7), or nuclear factor k beta (NE
kB). This pathways leads to the expression of Interferon [3 (LFN[3).
RLRs are specifically responsible for detecting viral infection by binding to double
stranded RNA (dsRNA). Many viruses synthesize dsRNA during replication and they are
recognized by these receptors. The class of RLRs encompass the proteins RIG-I (Retinoic
Inducible Gene I), MDA5 (Melanoma differentiation-association gene), and LGP2 (Laboratory
of Genetics and Physiology 2). RIG-I and MDA5 can both bind to dsRNA and signal for
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interferon induction. LGP2 also has the ability to bind to dsRNA but does not have the capability
to signal but instead can enhance the signaling capability of MDA5 (3).
Domain Organization and Stnictrtre
Both RIG-I and MDA5 contain tandem CARD (Caspase Recruitment Domains)
domains followed by helicase domains and a C-Terminal Domain (CTh) (Figure 1) (5). The
CARD domains are able to signal via a protein termed mitochondrial Anti-Viral Signaling
protein (MAVS) located on the outer mitochondrial membrane. The helicase and CTh are
important for RNA recognition and binding. LGP2 also contains a helicase domain and a CTD.
However, it lacks the CARD domains necessary for signaling, and it is thought that LGP2 plays
a role in modulating MDA5 and RIG-I activation by binding to dsRNA (2).
Activation andBinding ofdsRWA
When viral dsRNA is not present in the host cell, RIG-I has been shown to be in an
auto-repressed state, where the CARD domains are folded and bound to the helicase domains.
The CARD domains are sequestered in this state but when UsRNA is present the receptor is able
to activate by exposing its CARD domains (6). Unlike RIG-I however, it is thought that the
CARD domains of MDA5 are not sequestered in the absence of the ligand (7). Although IVDA5
is very similar structurally to RIG-I, there are still significant differences. The presence of a 5’
triphosphate moiety is important for the differentiation between host and viral RNA (21). While
MDA5 can bind ligands with this moiety, RIG-I more specifically recognizes dsRNAs that have
blunt ends or ssRNA with 5’ triphosphates (21). MDA5 preferentially binds to larger strands of
UsRNA with lengths generally greater then 1,000 base pairs (bp) unlike RIG-I which binds at the
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ends to dsRNAs shorter then 300 base pairs (4). It is also interesting that MDA5 forms a filament
of molecules once it binds to the UsRNA. Once MDA5 forms a filament on the dsRNA, the
2CARD domains are spatially very close to each other and this favors the oligomerization
process of the CARDS on the dsRNA (1). This is important for downstream signaling since this
favors oligomerization of the MAVS CARD domains as well when binding on the mitochondrial
membrane.
The CTD of RIG-I is important for ligand recognition because it allows RIG-I to
bind with high affinity to dsRNAs containing a 5’ triphosphate. RIG-I is also able to bind RNA
through interactions with the RNA backbone as well as with the bases, and this coordinates the
helicase domain around the dsRNA. This rearrangement induces formation of the AlP binding
pocket in the helicase domain. Upon ATP binding RIG-I is activated and can signal through its
2CARD domains via interactions with MAVS (9,11). RIG-I and MDA5 also bind K63-linked
polyubiquitin chains (PolyUb) during activation. PolyUb chain lengths could vary greatly in size
and could be as small as two units when binding to RIG-I. PolyUb chains bind covalently or non
covalently to RIG-I 2CARD. A crystal structure of the complex of RIG-I CARD domains and
PolyUb shows that the PolyUb chains help to assemble the CARD domains intro a tetramer.
Mono ubiquitin is not enough to induce oligomerization however since it does not provide
enough contact with the receptors to be a favorable reaction (14, 15). It is believe that formation
of the RIG-I tetramer induces MAVS to oligomerization, likely by adding onto the RIG-I
tetramer scaffold. When RIG-I is held in an autorepressed state, the CARD domains are
sterically hindered from binding to PolyUb as well as preventing signaling to MAVS (1,1 1).
Although both RIG-I and MDA5 contain helicase domains, they do not function as
traditional RNA helicases would or have that activity. ATP binding is important for the function
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that contains an N-terminal his tag followed by a SUMO tag and a ThV cleavage site upstream
of a cloning site where we will insert our gene of interest. A mammalian expression vector
containing the LGP2 gene was obtained through Addgene (plasmid # 58681). Forward and
reverse primers were designed and obtained from IDT (Shown below) and were used in two 25
p.L PCR reaction mixtures under the following conditions:
Table 1:
Component RXN1 (i.tl) RXN2 (iii)
Phusion Mix 12.5
forward 1 1
Reverse 1 1
Template 1 2.5
H20 9.5 8
Primer Sequenes:
Forward - S’TACTTCCAATCCAATGCMTQGAGCTTCGGTCCTACCAATGGGAGGTGA3’
Reverse -5 ‘TTATCCACTTCCAATGTTATTAGTCCAGGGAGAGGTCCGACA3’
Vector Preparation:
The plasmid DNA was cleaved prior to the LIC treatment using the restriction
enzyme SspI. About 10 units of sspl were used for 1-2 ig of plasmid DNA in a total reaction
volume of 50 pL. The sample was run on a 1% agarose gel for 1 hour and the vector band was
cut out of the gel.
LIC (Ligation Independent Cloning) Reactions:
A LIC reaction was done treating with 14 DNA polymerase. 14 polymerase has
interesting activity as it is an enzyme with 3’ to 5’ exonuclease activity and is able create
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overhangs so that the vector and the insert are complementary to each other. The following
reaction mixtures were set up for both the vector and the insert for total reaction volumes of 25
.tL each.
Vector: Insert:
10 iL linearized vector 4 iiL Purified PCR
2.5 j.tL NEB buffer 2 2.5 iL NEB buffer 2
2 .rL UGTP (25 mM) 2 iiL UCTP (25 mM)
.5 iL T4 Polymerase .5 1iL T4 Polymerase
.2LBSA .2[JLBSA
9.8 ± water 15.8 1.tL water
The reactions were allowed to incubate at 22°C for 40 minutes and then the T4 Polymerase was
heat denatured at 75°C for 20 minutes. following the reaction with 14 Polymerase, an annealing
reaction was set up containing the vector and insert. 0.2 j.tL of 250 mM EDTA was added to each
reaction and allowed to incubate at room temperature for 5 minutes. The reactions were then
transformed into Rosetta II competent cells.
Expression ofLGF2:
15 mL aliquots of LB were inoculated with colonies from the transformed Rosetta
U cells. The 15 mL cultures were incubated in a shaker for 16 hours at 37°C and 250 rpm.
Following growth of the culture overnight, the 15 mL culture was transferred to 250 mL of LB
broth in a 1 L flask containing carbemcillin and chioramphenicol. This was once again incubated
in a shaker at 250 rpm and 37°C. Once the absorbance reading at 600 nm reached approximately
0.80, the flask was put on ice and the temperature of the culture was monitored until it reached
16°C. At this point Isopropyl f3-D-1-thiogalactopyranoside (IPTG) was added to the sample in
order to induce expression of LGP2 at a final concentration of 0.50 mM. The culture was
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incubated in a shaker at 250 rpm and 16°C for 12 hours. The cells were spun down the next thy
at 8,000 rpm for 30 minutes.
Cell Lysis:
The post induction cell pellets were thawed on ice and were resuspended in
approximately 20 mL of low salt lysis buffer. The same procedure was done as well with a high
salt buffer.
Buffer:
20 mM Tris
150 mMNaCl
pH 7.5
High Salt:
25 mM HEPES pH 7.4
500 mMNaCl
10 mM Imithzole
5 mM BME
10 % glycerol
Cell lysis was performed using a sonicator. The resuspended sample was sonicated
6 times for 15 seconds each time with 30 second. Once sonication was complete, the sample was
centrifuged at 9,000 rpm for 3 minutes.
LGF2 Expression in Arctic Express cells:
LGP2 was transformed into the Arctic Express cell line from Agilent Technologies
using the same protocol as described previously. However, with the Arctic Express cell line, the
flask was put on ice at an absorbance reading of approximately 0.90. Once induced, the culture
was incubated at 12°C and 250 rpm for 24 hours. The sample was then centrifuged at 9,000 rpm
for 30 minutes.
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Autoinduction:
The Rosetta II and Arctic Express transformed cells were inoculated in 500 mL of
5 grams of tryptone and 2.5 grams of yeast extract in four different conditions.
Table 2:
Conditions
1 .2 % Glucose, .2% Lactose
2 .05% Glucose, .2% Lactose
3 .10% Lactose, .5% Glucose
4 .5% Lactose, .10% Glucose
Cell lysis using Bug3uster:
The same procedures were followed as described previously when growing Arctic
Express cells. However, once the high salt lysis buffer was added, 1 mg/mL of lysozyme was
added to the cell lysate and it was stirred at 4°C for 10 minutes. The sample was then frozen at -
80°C and thawed once again on ice. 1 mL of lox Bugbuster (Novagen) and 75 pL of Benzonase
Nuclease were added to the cell lysate sample. This was stirred at 4°C for 20 minutes until the
mixture became less viscous. The sample was centrifuged at 14,000 rpm for 30 minutes.
Nickel NTA Chromatography
The supematant was incubated in nickel beads from GE Healthcare (Ni Sepharose 6 Fast
Flow) for 30 minutes. The following buffers were made for use in the nickel column.
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Wash 1:
25 mM HEPES pH 7.4
1 MNaC1
10 mM Imidazole
5 mM BME
10% glycerol
Wash2:
25 mM HEPES pH 7.4
300 mMNaC1
20 mlvi Imidazole
5 mM BME
10% glycerol
Elution:
25 mMHEPES pH 7.4
300 mMNaC1
160 mlvi Imidazole
5 mM BME
10 % glycerol
The elutions were pooled and run down a heparin column using the following buffers.
Heparin A:
25 mlvi HEPES pH 7.4
100 mMNaCl
5 mM BME
10 % glycerol
Heparin B:
25 mM HEPES pH 7.4
1 MNaC1
5 mM BME
10% glycerol
Results:
We were able to successfully design primers to amplify the LGP2 gene. A PCR reaction
was done with reactions in duplicate to ensure at least one reaction worked (Figure 3). Table 1
shows the differences between reaction one and reaction two. A band was expected to show up at
around 2000 base pairs, which is seen in all four reactions indicating that they worked.
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We were able to clone LGP2 into an expression vector suitable for use in E. coil cells and
incorporated a cleavable SUMO tag (figure 4). This expression of a fusion protein is a common
technique as its aids in solubilizing the protein of interest. In this case, the SUMO tag is a
solubility tag, which is added to a less soluble protein (LGP2). A Thy cleavage site was include
so the SUMO tag could be cleaved once LGP2 was purified.
We originally used Rosetta II cells in a low salt (150 mM NaC1) buffer in order to
solubilize LGP2. LGP2 has a molecular weight of 75 kDa but due to the addition of the SUMO
tag we expected a band around 85 kDa. A band around this region was observed (figure 5).
There may be some LGP2 in the supematant but the majority of the protein appears in the cell
pellet indicating that the protein is not soluble.
In order to solubilize LGP2, we increased the salt concentration of the lysis buffer to 500
mM NaCl. This was done since due to their electrostatic properties, some proteins are more
soluble in higher ionic strength buffers. When analyzed on an SDS gel after lysis in a high salt
buffer, LGP2 appeared again in the whole cell lysate and in the pellet but none showed up in the
supernatant (Figure 6). The use of a different lysis buffer did not appear to have any effect on
solubility.
As another effort to purify LGP2, we used Arctic Express cells in order to grow LGP2.
Arctic Express cells were specifically engineered to in order to increase the yield of soluble
proteins in E. coil. At normal temperatures, high levels of expression of target proteins in cells
can lead to insoluble aggregates. This can happen since the chaperones in the cells become
overloaded with the amount of protein. However, Arctic Express cells provide additional
chaperones. We hypothesized that by using this type of cell line, we would be able to obtain
soluble LGP2. We saw a band appear around 70 kDa when using a low salt buffer in these cells
‘S
(figure 7). This band could have been LGP2 but it showed up lower on the gel then was
expected. Nonetheless, purification was continued using Nickel NTA chromatography. The His6
tag is able to bind to many metal ions including nickel. for this reason, LGP2 binds to the
column and can be eluted off using a high concentration of imidazole. The column was
equilibrated in the low imidazole buffer and a step gradient was used in order to increase
imidazole concentration.
When the fractions were analyzed on an SDS gel (Figure 8), a band appeared in the last
several fractions that could have been LGP2. Next, we used a ThV protease to cleave the
solubility tag (SUMO) that was engineered to assist with the solubility of LGP2. On an SDS gel,
we observed a band appear in the cut version between 45 and 35 kDa (Figure 9) that is difficult
to visualize. More importantly, there was no decrease in size of the original band due to removal
of the $UMO tag, suggesting that either the protease did not work or that this was not the desired
construct. But nonetheless, we determined that attempting a different approach might prove
successful.
Expression of LGP2 was performed again in Rosetta II and Arctic Express cells using a
technique called autoinduction. Instead of inducing by IPTG addition, this media contains
glucose and lactose, which repress expression of the protein. This technique can yield
substantially more cells per liter than when using LB broth. Therefore, it was thought that by
simply producing more total cells, we might obtain LGP2. However, although cell pellets of
about 8 g/liter were obtained, no proteins seem to be present on the gel and no band is present
where we would expect LGP2 (Figure 10).
Next, we decided to try a chemical lysis method, which may have been gentler on our
protein of interest. We used Bugbuster, which contains detergents that can chemically lyse cells.
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Up until this point we had been mechanically lysing cells using sonication. When using
Bugbuster we were able to solubilize LGP2 in a high salt buffer and it shows up in the eluent on
NiNTA chromatagraphy (Figures 11 and 12). The column was incubated with the high salt lysis
buffer and the flow through was collected. 30 mL of both wash 1 and wash 2 were run down the
column followed by 3 5 mL portions of the elution buffer. The gel for the NiNTA column shows
a band expected for LGP2 in the first two elutions. The first two elutions were pooled and
heparin affinity chromatography was used to further purify the protein. The heparin B buffer was
used elute the protein from the heparin column. Heparin is a molecule with a highly negative
charge and is used as an affinity ligand for many biological molecules. Typically, proteins that
bind RNA such as LGP2 have basic regions that will also bind negatively charged heparin
molecules. For this reason, heparin chromatography was a suitable method for purifying LGP2.
An $DS gel of the fractions from the heparin column shows a band expected in the area that
LGP2 should appear. However, the band is much fainter after running the sample through the
heparin column compared to the NiNTA slurry. After the NINTA we obtained approximately 3.1
mg of protein but after heparin this was reduced to about 0.9 mg leading us to conclude that we
lost a significant amount. Although, we were able to successfully express and purify LGP2, we
were not able to obtain a large quantity of the protein.
In summary, expression of LGP2 in Arctic Express cells in conjunction with the use of
Bugbuster, and a high salt buffer led to the production of soluble LGP2 protein. This protocol
can be further optimized to produce LGP2 in larger quantities for use in biophysical analyses.
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Future Directions:
Although it may prove to be difficult to continue pursuing purifying LGP2, it may be
useful to use different induction temperatures when inducing with IPTG. In the previous
procedures, induction was done at 16°C for Rosetta II cells and 12°C for Arctic Express cells.
Induction at multiple temperatures was never attempted and this may help in expression and
solubility of LGP2.
In addition to this, different absorbance readings can be used before inducing with IPTG.
In previous protocols, the protein culture was induced after an absorbance reading of about .8-. 9.
However, multiple protein samples could be made and induced at absorbance readings anywhere
from 0.5-1.2 at 600 nm.
Alternatively, different induction times could also be used. After inducing, a small 5 mL
sample could be taken from the culture every 3 hours and look for effects on the production of
LGP2. These could be some of the few future experiments in order to further pursue expressing
and purifying LGP2.
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Figure 1: This figure explains the domain organization of all three RLRs: RIG-I,
MDA5, and LGP2. It can be seen that RIG-I and MDA5 are very similar structurally
and contain CARD domains that can signal to MAVS. However, LGP2 is much shorter
and does not have this ability. from reference (5).
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Figure 2: This figure explains the function of RIG-I, MDA5, and LGP2. RIG-I is
able to bind to the terminus of the dsRNA and translocate with ATP hydrolysis and
form filaments. MDA5 on its own slowly forms unstable filaments and then is able
to form longer filaments and signal to MAV$. However, when LGP2 is present, it
appears to bind to the terminus of dsRNA and aid in rapid formation of MDA5
filaments and stabilizes these short filaments. It is now known how this entirely
works. From reference (5).
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RXN 1 RXN 1 RXN 2 RXN 2
2kb
1.5kb
Figure 3: Shown above is a 1% agarose gel of the PCR reaction done using the
forward and reverse primers, which were used for the LIC reaction. The reactions
were set up in duplicate so the first two columns and last two are the exact same. Refer
to table 1 for the reaction components. The reactions were set up in duplicate to ensure
that at least one would work. All 4 reactions worked as can be seen by all 4 bands
appearing as expected.
.1
3kb
—
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ATGAAATCTTCTCACCATCACCATCACCATGGTTCTTCTATGGCTAGCATGTCGGACTCAGAGTCATCJ\AGA
AGCTAAGCCAGAGGTCAAGCCAGAAGTCAAGCCTGAGACTCACATCAATTTAAAGGTGTCCGATGGAT CTT CAG
AGAT CTTCTTCAAGAT CAAAAAGACCACTCCTTTAAGAAGGCTGAT GGAAGCGTTCGCTAJGACAGGGTAAG
GAATGGACTCCTTAGATTCTTGTACGACGGTATTAGAATTCAAGCTGATCAGACCCCTGAAGATTTGGACAT
GGAGGATACGATATTATTGAGGCTCACAGAGAACAGATTGGT GGGAT CGAGGAAAACCT GTACTT CCAAT CCA
ATGCATGGAGCTTCGGTCCTACCAkTGGGAGGTGATCATGCCTGCCCTGGAGGGCAAGAATATCATCATCTGG
CT GCCCACGGGTGCCGGGAGACCCGGGCGGCTGCTTATGTGGCCAAGCGGCACCTAGAGACTGTGGATGGAGC
CAAGGTGGTTGTATTGGTCAACAGGGTGCACCTGGTGACCCAGCATGGTGPAGAGTTCAGGCGCATGCTGGATG
GACGCTGGACCGTGACA1CCCTGAGTGGGGACATGGGACCACGTGCTGGCTTTGGCCACCTGGCCCGGTGCCAT
GACCTGCTCATCTGCACAGCAGAGCTTCTGCAGATGGCACTGACCAGCCCCGAGGAGGAGGAGCACGTGGAGCT
CACTGTCTTCTCCCTGATCGTGGTGGATGAGTGCCACCACACGCACAAGGACACCGTCTACA1CGTCATCATGA
GCCAGTACCTAGACTTACTCCAGAGGGCACAGCCGCTACCCCAGGTGCTGGGT CT CACAGCCT CC CCAGG C
ACTGGCGGGGCCTCCAAACTCGATGGGGCCATCA1LCCACGTCCTGCAGCTCTGTGCCAACTTGGACACGTGGTG
CATCATGTCACCCCAGA.CTGCTGCCCCCAGCTGCAGGAGCACAGCCAACAGCCTTGCAAACAGTACAACCTCT
GCCACAGGCGCAGCCAGGATCCGTTTGGGGACTTGCTGAGAAGCTCATGGACCAAATCCATGACCACCTGGAG
ATGCCTGAGTTGAGCCGGAATTTGGGACGCATGTATGAGCAGCAGGTGGTGAfiLGCTGAGTGAGGCTGCGGC
TTTGGCTGGGCTTCAGGAGCACGGGTGTATGCGCTTCACCTGAGGCGCTACAATGACGCGCTGCT CATCCATG
ACACCGTCCGCGCCGTGGATGCCTTGGCTGCGCTGCAGGATTTCTATCACAGGGAGCACGTCACTAACCCAG
ATCCTGTGTGCCGAGCGCCGGCTGCTGGCCCTGTTCGATGACCGCAAGAATGAGCTGGCCCACTTGGCAACTCA
TGGCCCAGAGALTCCAAACTGGAGATGCTGGAAAGATCCTGCAAGGCAGTTCAGTAGCTCTACAGCCCTC
GGGGTATCATCTTCACCCGCACCCGCCAAAGCGCACACTCCCTCCTGCTCTGGCTCCAGCAGCAGCAGGGCCTG
CAGACTGTGGACATCCGGGCCCAGCTACTGATT GGGGCTGGGAACAGCAGCCAGAGCACCCACATGACCCAGAG
GGACCAGCGAGTGATCCAGAAGTTCCAAGATGGACCCTGAACCTTCTGGTGGCCACGAGTGTGGCGGAGG
AGGGGCTGGACATCCCACATTGCAATGTGGTGGTGCGTTATGGGCTCTTGACCAATGAATCTCCATGGTCCAG
GCCAGGGGCCGTGCCCGGGCCGATCAGAGTGTATACGCGTTTGTAGCAACTGAAGGTAGCCGGGAGCTGAAGCG
GGAGCTGATCACGAGGCGCTGGAGACGCTGATGGAGCAGGCAGTGGCTGCTGTGCAGAATGGACCAGGCCG
AGTACCAGGCCAFLGAT CCGGGATCTGCAGCAGGCAGCCTTGACCAAGCGGGCGGCCCAGGCAGCCCAGCGGGAG
AACGAGCGGCAGCAGTTCCCAGTGGAGCACGTGCAGCTACTCTGCATCAACTGCATGGTGGCTGTGGGCCATGG
CAGCGACCTGCGGAAGGTGGAGGGCACCCACCATGTCA]TGTGAACCCCAACTTCTCGAACTACTATAATGTCT
CCAGGGATCCTGTGGTCATCACAGTCTTCAGGACTGGAAGCCTGGGGGTGTCATCAGCTGCAGGAACTGT
GGGGAGGTCTGGGGTCTGCAGATGATCTACAAGTCAGTGAAGCTGCCAGTGCTCAAAGTCCGCAGCATGCTGCT
GGAGACCCCTCAGGGGCGGATCCAGGCCAAAAPLGTGGT CCCGCGTGCCCTTCTCCGTGCCTGACTTTGACTTCC
TGCAGCATTGTGCCGAGAACTTGTCGGACCTCTCCCTGGACTGA
His Tag
TEV Cleavage Site
SUMO Tag
LGP2 sequence
Figure 4a: Shown above is the sequencing results showing that LGP2 was
successfully cloned into an expression vector suitable for use in F. coil. This is a
nucleotide sequence showing the His tag followed by a SUMO tag and ThV cleavage
site. The tags are color coordinated as shown.
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MKSSHHHHHH 55 SMASMSDS EVNQEAKPEV KPEVKPETHI NLKVSDGSSE I FFKIKKTTP
LRRLMEAEAK RQGKEMDSLR FLYDGIRIQA DQTPEDLDME DNDIIEAHRE QIGGIEENLY
FQSNANELRS YQWEVIMPAL EGKNIIIWLP TGAGKTRAAA YVAKRHLETV DGAKVVVLVN
RVHLVTQHGE EFRRNLDGRW TVTTLSGDMG PRAGFGHLAR CHDLLICTAE LLQMALTSPE
EEEHVELTVF SLIWDECHH THKDTVYNVI MSQYLELKLQ RAQPLPQVLG LTASPGTGGA
SKLDGAINHV LQLCANLDTW CIMSPQNCC? QLQEHSQQPC KQYNLCHRRS QDPFGDLLKK
LMDQIHDHLE MPELSRKFGT QMYEQQWKL SEAAALAGLQ EQRVYALHLR RYNDALLIUD
TVRAVDALAA LQDFYHREHV TKTQILCAER RLLALFDDRK NELAHLTHG PENPKLEMLE
KILQRQFSSS NSPRGIIFTR TRQSAHSLLL WLQQQQGLQT VDIRAQLLIG AGNSSQSTHM
TQRDQQEVIQ KFQDGTLNLL VATSVAEEGL DIPHCNVVVR YGLLTNEISM VQARGRARAD
QSVYAFVATE GSRELKRELI NEALETLMEQ AVAVQKNDQ AEYQAKIRDL QQAALTKRAA
QAAQRENERQ QFPVEHVQLL CINCMVAVGH GSDLRKVEGT HHVNVNPNFS NYYNVSRDPV
VINKVFKDWK PGGVISCRNC GEVWGLQMIY KSVKLPVLKV RSMLLETPQG RIQAKKWSRV
PFSVPDFDFL QHCAENLSDL SLD
His Tag
TEV Cleavage Site
SUMO Tag
LGP2 sequence
Figure 4b: Shown above is the sequencing results showing that LGP2 was
successfully cloned into an expression vector suitable for use in E. coil. This is a
amino acid sequence showing the His tag followed by a SUMO tag and 1EV cleavage
site. The tags are color coordinated as shown.
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Sup Pellet
LGP2
Figure 5: The SDS gel above shows the expression of LGP2 in Rosetta II cells
following sonication and centrifugation. IPTG was used to induce at L 6°C. The
first column shows the supernatant while the second shows the cell pellet. LGP2
appeared to express with the majority in the cell pellet.
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LGP2
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Figure 6: The SDS gel above shows the expression of LGP2 in Rosetta II cells after being
lysed in a high salt buffer compared to previous procedures with a lower salt concentration.
WC represents the whole cell lysate, P represents pellet, and sup represents the supernatant.
This proved to be unsuccessful as LGP2 appeared to express in the pellet and none appeared
in the supernatant.
wcP wc sup
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Low salt High Salt
wcP SUP WCP SUP
Figure 7: This figure shows the SDS gel of LGP2 expression in Arctic Express
cells followed by lysis in a high salt buffer and a low salt buffer. WC is the whole
cell lysate, P is pellet, and SUP is supernatant. LGP2 seems to express and is
soluble when lysed in the low salt. However, the band appears lower on the gel
then expected.
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Figure 8: This figure shows the fractions from running LGP2 down a Nickel column. The
fractions (fractions 3,8,16,21,26,27,28) were run in the gel in order to test for the presence of
LGP2. The last three fractions were contained a band that could be LGP2 as shown by the
arrow and were collected.
1;181 kDa115 kDa
82 kDa
64 kDa
48 kDa
37 kDa
LGP2
•
%••.
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Figure 9: This gel shows the 1EV reaction which cut LGP2 in order to make
sure our target band in previous gels was in fact the target protein. However, a
band appears in the cut sample between 37 kDa and 48 kDa. We are not sure
why this happens but this leads us to believe that this isn’t LGP2 since SUMO is
not this size nor is LGP2.
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Figure 10: This shows the autoinduction samples where specific amounts of
glucose and lactose were added as shown in table 2. R in the column labels
indicates Rosetta cells and AE indicates Arctic Express cells. Each number
indicates the conditions as labeled in table 2 in materials and methods. No
expression of LGP2 is seen in any of the conditions.
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Figure 11: This figure shows a gel of the protein sample after it went through a
nickel bead column after use of bugbuster. Bugbuster was used in this case over
traditional sonication. It appears that LGP2 might be present in the first two elutions.
FT is flowthrough, W indicates wash, and E indicates elution.
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LGP2
181 kDa
115 kDa
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Figure 12: This figure shows the fractions from the heparin column
indicating the presence of LGP2 in the second and third rows from the left.
In the next steps, a ThV reaction will be done to cleave LGP2.
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